Research Journal

Dermal Encapsulation Research Journal

Research briefings on lipid nanovesicles, nanocarrier comparisons and topical bioavailability, written from primary patents and peer-reviewed literature and updated as the evidence changes.

Answer first

This journal publishes independent scientific briefings on dermal encapsulation. Each article opens with an Answer-First summary, cites granted patents and PubMed or Crossref-indexed papers inline, and carries author, technical reviewer, publication and update dates. Articles contain no product or brand promotion. Filter by category or search by molecule, carrier or concept.

6 briefings

Transdermal Science

Hydrophilic + Lipophilic Co-Loading: How Dual-Solubility Nanocarriers Deliver Multi-Active Formulations in One Step

Most multi-active routines exist because one vehicle cannot hold both water-loving and oil-loving molecules. Dual-solubility nanocarriers change that, which matters for both regimen design and transdermal science.

3 min read

Barrier & Clinical Tolerability

Vehicle Engineering in Clinical Dermatology: Reducing Retinoid & Acid Drop-Off Through 24-Hour Controlled Release

Patients rarely stop a retinoid or acid because it fails. They stop because the first weeks are uncomfortable. How vehicle design, and controlled release in particular, can change that adherence curve.

3 min read

Nanocarrier Comparisons

Why K-Beauty Formulators Are Hunting for Low-Cost Alternatives to Pharmaceutical Lipid Nanovesicles

Fast-cycle cosmetic markets reward novelty, speed and margin, while pharmaceutical nanovesicles reward characterisation and patience. A structural look at why carrier ingredients get traded down, and what is lost when they do.

3 min read

Nanocarrier Comparisons

Zeta Potential (-20mV to -100mV) Explained: Why Most Liposomal Serums Clump and Degrade on the Shelf

Zeta potential is the single number that best predicts whether a nanovesicle dispersion will still be a dispersion in six months. What it measures, what it does not, and why the −20 to −100 mV window matters.

3 min read

Molecule Bioavailability

Why 15% Unencapsulated Azelaic Acid Stings—And How Lipid Bilayer Entrapment Solves Stratum Corneum Irritation

Azelaic acid works on acne, rosacea and melasma, but burning and stinging stop many patients from continuing. This briefing explains where the sting comes from and how vesicle entrapment changes what nerve endings feel.

3 min read

Nanocarrier Comparisons

Cetosomes® vs. Exosomes in Topical Skincare: Stability, Regulation & Bioavailability Compared

Exosomes are the most talked-about vesicles in skincare, and Cetosomes® are among the most rigorously characterised. A side-by-side reading of their composition, shelf stability, regulatory status and delivery evidence.

4 min read

Methodology

Content is written from primary sources: granted US patent text, peer-reviewed journals indexed in PubMed or Crossref, and regulator publications. Numerical specifications are quoted exactly as reported in the cited source. Where data are illustrative models rather than measurements, the figure says so.

Conflict of interest & scope

Cetosomes.com is operated in association with parties that manufacture and dispense Cetosome®-based formulations. This site explains vehicle and delivery biophysics; it does not diagnose, treat or prescribe. Clinical decisions belong to a qualified dermatologist or physician. Research articles in the Journal carry no product or brand references.